| Linda Mary Dales, MD | |
|
1516 23rd Ave, Meridian, MS 39301-4026 | |
| (601) 703-3820 | |
| (601) 703-0125 |
| Full Name | Linda Mary Dales |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | 1516 23rd Ave, Meridian, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366498677 | NPI | - | NPPES |
| 304138 | Medicaid | SC | |
| P00326699 | Other | NC | RAILROAD MEDICARE |
| 00358088 | Medicaid | MS | |
| 12700 | Other | NC | BCBSNC |
| 8912700 | Medicaid | NC | |
| GP4505 | Medicaid | SC | |
| 188453 | Other | NC | MEDCOST |
| 2119923 | Other | NC | CIGNA HEALTHCARE |
| Mailing Address | Practice Location Address |
|---|---|
| Linda Mary Dales, MD 1516 23rd Ave, Meridian, MS 39301-4026 Ph: (601) 703-3820 | Linda Mary Dales, MD 1516 23rd Ave, Meridian, MS 39301-4026 Ph: (601) 703-3820 |
News Archive
The investigational PARP inhibitor talazoparib caused regression of patient-derived xenografts (PDXs) of triple-negative breast cancers (TNBC) that had BRCA mutations and also those that did not have BRCA mutations but had other alterations in DNA damage-repair pathways.
Russian scientists have found that neoadjuvant chemotherapy in patients with breast cancer can stimulate evolution of the tumor. The results of the research conducted by Nicholay Litvyakov, D.Sc. at Cancer Research Institute, Head of the Tumor Virology Laboratory, and TSU researcher Marina Ibragimova, were published in "Siberian Journal of Oncology."
The side effects of the standard medication for Parkinson's disease have long been a preoccupation of brain researchers. Now Daniella Rylander has presented new findings in a recently defended PhD thesis at Lund University that provide hope of more effective medication for those who suffer from the nerve cell disease.
In the third quarter of 2009, sanofi-aventis generated net sales of euro 7,400 million, up 8.0% on a reported basis. Exchange rate movements had a favorable effect of 2.0 percentage points, with the appreciation of the U.S. dollar (and to a lesser extent the yen) against the euro more than offsetting the unfavorable effects of some other currencies.
A team of researchers led by Boston University School of Medicine (BUSM), has found treatment of selected immunoglobulin light chain (AL) amyloidosis patients with high-dose melphalan and autologous stem cell transplantation (HDM/SCT) resulted in a high organ response rate and increased overall survival (OS), even for those patients who did not achieve a hematologic complete response.
› Verified 3 days ago
Charandle S Jordan, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1314 19th Ave, Meridian, MS 39301 Phone: 601-483-0011 | |
Dr. Frederick T Duggan, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1600 22nd Ave, Medical Towers Iii, Meridian, MS 39301 Phone: 601-483-5322 Fax: 601-581-2289 | |
Christopher W Swift, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1314 19th Ave, Meridian, MS 39301 Phone: 601-703-4078 | |
Dr. Adam M Parker, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1800 12th St, Meridian, MS 39301 Phone: 601-484-6700 | |
Dr. Ruba F. Barakat, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1600 22nd Ave, Meridian, MS 39301 Phone: 601-483-5322 Fax: 601-581-2289 | |
Dr. William Greg Thaggard, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2024 15th St Fl 2, Meridian, MS 39301 Phone: 601-553-2000 Fax: 601-553-6746 | |
Dr. Vincent Craig Dungan, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1800 12th St, Suite 1d, Meridian, MS 39301 Phone: 601-703-9541 Fax: 601-703-9947 |